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Conclusions: The results of the GENERATION study suggest that high plasma levels of 
CRP are not related 10 the rate of ISR after successful CS. More studies are needed to 
elucidate this issue. 
CRP quartiles j*t 2”6 gnd 4th p 
Median mgldl 0.50 0.54 0.64 1.01 
% Incidence 32.1 33.8 37.3 36.8 0.69 
1175-184 Human lmmunodeficiency Virus Infection and High C- 
Reactive Protein Correlates With Increased In-Stent 
Restenosis Rate 
Swros Kokolis, George Dangas. Roxana Mehran, Ronald Kokolis, Zoran Lasic, Ruby 
Hanna, Michael Collins, Sriram lyer, Makoto Hirose, Yoshio Kobayashi, Edward Kreps, 
Gregg W. Stone, Martin B. Leon, Jeffrey W. Moses, Cardiovascular Research 
Foundation, New York, NY, Lenox Hill Hospital, New York, NY 
Objective: We evaluated the outcome of patients with Human lmmunodeficiency Virus 
(HIV) infection who had percutaneous coronary interventions (PCI) with stent implanta- 
tion. Background: HIV and anti-retroviral therapy may propagate intimal proliferation and 
inflammation. These cascades have been postulated to accelerate in stent restenosis. 
The atherogenic effects of various inflammatory cytokines that are up-regulated by HIV 
may contribute and accelerate coronary artery disease (CAD). C-reactive protein (0.0 - 
5.0 mgA) appears to correlate with increased atherogenesis. It is hypothesized that 
increased levels of C-reactive protein (CRP) correlate with increased in stent restenosis. 
Methods: 30 patients with HIV who had PCI with stents from 1997 to 2002 were studied. 
All patients had repeat angiography. In srent restenosis was considered when there was 
greater than 50% luminal diameter stenosis of the previously stented lesion. Results: The 
patients had similar baseline characteristics and procedural variables. Restenosis results 
are shown in the table. Of the 22 patients with in stent restsnosis. 20 had an elevated 
CRP (90%). CONCLUSIONS: HIV patients have a very high in stent restenosis rate. This 
exaggerated neo-intimal response may be related to high CRP levels. 
n &stenosis 
Rate 
All HIV Patients 30 74% (22/30) 
HIV patients with no HIV therapy 12 67% (8/12) 
HIV patients with elevated C-reactive protein (0.0 - 5.0 mg/L) 20 67% (20/30) 
HIV with No Anti-retroviral Therapy and elevated C-Reactive 13 72% (13/18) 
protein 
HIV with Anti-retroviral Therapy and elevated C-Reactive protein 7 58% (702) 
1175-185 IL-6 174GIC Polymorphism Influences Restenosis 
After Coronary Stent Implantation by Increased 
Inflammation and Platelet Activation 
Tania Kottmann, Cornelia Piper, Martin Farr, Klaus P. Mellwig, Hermann Mannebach, 
Knut Kleesiek. Dieter Horstkotte, Heart Center North Rhine-Westphalia, Bad 
Oeynhausen, Germany 
Background: The G allele of interleukin-6 (IL-6) -174GlC polymorphism is associated 
with an enhanced plasma level of IL-6 after bypass surgery. It’s influence on the inflam- 
mation and on the mean platelet volume (MPV), a parameter for activated platelets, after 
coronary stent implantation (ST) is unknown. Furthermore, there is no data about the 
influence of -174GlC on restenosis after ST. 
Methods: Between 9101 and 3102 we enrolled 65 patients (58 men, mean age: 63+9 
years) before ST. -174G/C genotype and levels of IL-6, C-reactive protein (CRP) and 
MPV were determined before ST, 3h, 6h. 12h, 24h, 48h, and 7 days thereafier. After 6 
months, control coronarangiography was performed to quantify restenosis. 
Results: -174G/C-genotypes presented as: 31% GG, 46% GC and 23% CC. After 6 
months. coronary restenosis (2 50%) was angiographically documented in 45% of GG, in 
30% of GC and in 13% of CC genotype (comparison GG vs. CC: p<O.O5).Conclusions: 
1. The G allele of -174G/C is associated with significantly higher levels of IL-6 resulting 
in significantly higher increase of CRP and MPV after stenting. 2. The risk for rsstenosis 
in homozygous carriers of the G allele is about three times higher than in patients without 
G allele, which might be explained by the enhanced platelet activation and inflammatoty 
response after stenting. 
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Higher Restenosis Rates Among Apo E4 Versus Apo E2 
Patients After Coronary Stenting: A Potential Genetic 
Etiology for Restenosis 
Ravish Sachar, Rothashav Dhir. Adrian Messerli, Cameron Haery, Gregory Pearce, 
Dennis L. Sprecher, The Cleveland Clinic Foundation, Cleveland, OH 
Background: The apolipoprotein (apo) E4 allele is associated with an increased risk of 
atherosclerosis, but studies on the role of Apo E4 allele in restenosis after coronary 
angioplasty have yielded conflicting results. The effect of the apo E4 allele on restenosis 
after stenting remains undefined. Methods After elective coronary stsnting, follow-up 
angiography (n=ll4) or stress testing (n=46) was performed at a minimum of 5 months 
after the index procedure. Restenosis was defined as 250% by quantitative coronav 
angiography, or ischemia in the stented territory by stress testing. Data from stress test- 
ing were used only in patients who had single vessel disease, a normal study prior 10 
stent placement, and those without a history of bypass surgery. Resufts: Between 1995 
and 2001, coronaiy stems were placed and Apo E genotyping was performed in 160 
patients (80% male, mean age 57+/-10 ). Genotype analysis revealed 0.8% (1) E2IE2, 
10% (16) E2/E3, 64% (101) E3/E3, 21% (34) E3/E4, and 4.4% (7) E4/E4 alleles. Rest- 
enosis rates were 18% for E2 alleles, 32% for the E3/E3 allele, and 45% for E4 alleles (p 
for trendc0.03). Apo E4 carriers had a significantly higher restenosis rate compared to 
E2 carriers (p=O.O47). but not compared lo all non-carriers (p=O.45). In a multivariate 
analysis, there was a trend towards higher restenosis rates among E4 carriers as com- 
pared to E2 carriers (p=O.O59). Conclusiorr Carriers of the apo E4 allele have higher 
restenosis rates after coronary stenting as compared to apo E2 carriers. 
